Triple Strike Against HIV: Early Treatment Clears Virus in Newborn Primates
What Happened
Researchers led by Oregon Health & Science University found that a three-part treatment completely cleared HIV-like infection in newborn nonhuman primates when given within three days of exposure. The combination included standard antiretroviral therapy, broadly neutralizing antibodies, and an experimental antibody called leronlimab.
Key Takeaways
This is still pre-human clinical research, not an approved cure for babies or adults. But because some components are already approved or being tested separately in humans, researchers say the strategy could move toward clinical trials, likely first in adults recently exposed to HIV.